Definitive Healthcare reports Q3 EPS 9c, consensus 6c

Reports Q3 revenue $65.33M , consensus $ $63.71M. Adjusted EBITDA was $21.7M or 33% of revenue, compared to $16.4M, or 29% of revenue in Q3 2022. “Revenue and adjusted EBITDA for the quarter were both above the high-end of our guidance ranges for the quarter,” said Robert Musslewhite, CEO of Definitive Healthcare. “We were pleased with our increased adjusted EBITDA profitability in the quarter. We have been focused on becoming more efficient across all parts of the organization and it is nice to see that work yielding some measurable results. As we continue to pursue the large and growing healthcare commercial intelligence market, we’ll continue to take a balanced approach between growth and profitability and invest in strategic areas that should lay the foundation for faster growth when market conditions improve.”